About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Quality of Life for Pediatric Urolithiasis | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT06092203

Quality of Life for Pediatric Urolithiasis

The aim of this study is to assess the quality of life (QoL) in pediatric patients with urinary stone disease.

Lead sponsor: Mansoura University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ahmed R EL-Nahas, MD

CONTACT

+201221136899 ar_el_nahas@yahoo.com

Sponsors

Lead Sponsor

Mansoura University

This study will assess the quality of life (QoL) in pediatric patients with urinary stone disease using the pediatric quality of life (PedsQol) questionnaire in comparison to normal healthy age/sex matched population.

Age

2 - 18 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients who had urinary stones

Exclusion Criteria

•1. Patients presenting with obstructive uropathy or urosepsis.
•2. Recent (less than 4 weeks) surgical intervention for urinary stone disease.
•3. Indwelling urinary catheters or stents (urethral catheter, ureteral stents or nephrostomy tube).
•4. Associated mental illness or cognitive dysfunction.
•5. Associated chronic medical illness that may compromise QoL.

Related studies

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

NCT06956781 · PTSD, Trauma, and more

Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease

NCT06325280 · Pediatric ALL, Congenital Heart Disease, and more

HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)

NCT05451979 · Pediatric ALL, Transplant; Failure, Heart

Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring

NCT06867289 · Procedural Sedation and Analgesia, Pediatric ALL

RECRUITINGPhase 1

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

NCT07257419 · Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 23, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment100

Start dateFeb 2023

Last updatedOct 23, 2023

Condition

Locations shown

Urology and Nephrology Center

Al Mansurah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 23, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions